Listed

Novavax Inc

NVAXNasdaqCIK 1000694HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$56.7m, Q2 FY2026
Operating income−$54.9m, Q2 FY2026
Net income−$53.4m, Q2 FY2026
Novavax Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m187Revenue, Q3 FY2023, three months to 2023-09-30$187.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure291Revenue, Q4 FY2023, three months to 2023-12-31$291.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure93.9Revenue, Q1 FY2024, three months to 2024-03-31$93.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure415Revenue, Q2 FY2024, three months to 2024-06-30$415.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure84.5Revenue, Q3 FY2024, three months to 2024-09-30$84.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure88.3Revenue, Q4 FY2024, three months to 2024-12-31$88.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure667Revenue, Q1 FY2025, three months to 2025-03-31$666.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure239Revenue, Q2 FY2025, three months to 2025-06-30$239.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure70.4Revenue, Q3 FY2025, three months to 2025-09-30$70.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure147Revenue, Q4 FY2025, three months to 2025-12-31$147.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure140Revenue, Q1 FY2026, three months to 2026-03-31$139.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure56.7Revenue, Q2 FY2026, three months to 2026-06-30$56.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Cost of revenue$m98.9Cost of revenue, Q3 FY2023, three months to 2023-09-30$98.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure155Cost of revenue, Q4 FY2023, three months to 2023-12-31$155.0m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure59.2Cost of revenue, Q1 FY2024, three months to 2024-03-31$59.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure46.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$46.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure60.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$60.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure36.7Cost of revenue, Q4 FY2024, three months to 2024-12-31$36.7m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure14.1Cost of revenue, Q1 FY2025, three months to 2025-03-31$14.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure15.3Cost of revenue, Q2 FY2025, three months to 2025-06-30$15.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure21.5Cost of revenue, Q3 FY2025, three months to 2025-09-30$21.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure22.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$22.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure30.7Cost of revenue, Q1 FY2026, three months to 2026-03-31$30.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure14.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$14.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Research and development$m106Research and development, Q3 FY2023, three months to 2023-09-30$106.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure165Research and development, Q4 FY2023, three months to 2023-12-31$164.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure92.7Research and development, Q1 FY2024, three months to 2024-03-31$92.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure107Research and development, Q2 FY2024, three months to 2024-06-30$106.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure87.2Research and development, Q3 FY2024, three months to 2024-09-30$87.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure104Research and development, Q4 FY2024, three months to 2024-12-31$104.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure88.9Research and development, Q1 FY2025, three months to 2025-03-31$88.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure79.2Research and development, Q2 FY2025, three months to 2025-06-30$79.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure98.3Research and development, Q3 FY2025, three months to 2025-09-30$98.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure75.9Research and development, Q4 FY2025, three months to 2025-12-31$75.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure95.5Research and development, Q1 FY2026, three months to 2026-03-31$95.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure70.7Research and development, Q2 FY2026, three months to 2026-06-30$70.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reported70.7Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$70.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure78.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$78.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure48.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$48.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure43.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$43.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure31.7Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$31.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure34.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$34.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure28.8Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$28.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure26.7Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$26.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Operating income$m(126)Operating income, Q3 FY2023, three months to 2023-09-30−$125.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure(184)Operating income, Q4 FY2023, three months to 2023-12-31−$183.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(145)Operating income, Q1 FY2024, three months to 2024-03-31−$144.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure161Operating income, Q2 FY2024, three months to 2024-06-30$161.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure(134)Operating income, Q3 FY2024, three months to 2024-09-30−$134.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure(131)Operating income, Q4 FY2024, three months to 2024-12-31−$131.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure516Operating income, Q1 FY2025, three months to 2025-03-31$515.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure101Operating income, Q2 FY2025, three months to 2025-06-30$101.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(178)Operating income, Q3 FY2025, three months to 2025-09-30−$178.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure14.2Operating income, Q4 FY2025, three months to 2025-12-31$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(15.4)Operating income, Q1 FY2026, three months to 2026-03-31−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure(54.9)Operating income, Q2 FY2026, three months to 2026-06-30−$54.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Interest expense$m2.9Interest expense, Q3 FY2023, three months to 2023-09-30$2.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0001000694-23-000055.Report this figure4.1Interest expense, Q4 FY2023, three months to 2023-12-31$4.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-28, accession 0001000694-24-000007. Derived: 12-month figure less the 9-month figure.Report this figure4.1Interest expense, Q1 FY2024, three months to 2024-03-31$4.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-10, accession 0001000694-24-000031.Report this figure4.1Interest expense, Q2 FY2024, three months to 2024-06-30$4.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure4.2Interest expense, Q3 FY2024, three months to 2024-09-30$4.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure7.6Interest expense, Q4 FY2024, three months to 2024-12-31$7.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure5.7Interest expense, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure5.5Interest expense, Q2 FY2025, three months to 2025-06-30$5.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure5.5Interest expense, Q3 FY2025, three months to 2025-09-30$5.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure5.8Interest expense, Q4 FY2025, three months to 2025-12-31$5.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure4.9Interest expense, Q1 FY2026, three months to 2026-03-31$4.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure5.7Interest expense, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Income tax$m(0.7)Income tax, Q3 FY2023, three months to 2023-09-30−$697.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure1.7Income tax, Q4 FY2023, three months to 2023-12-31$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure2.3Income tax, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure2.2Income tax, Q2 FY2024, three months to 2024-06-30$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure(1.0)Income tax, Q3 FY2024, three months to 2024-09-30−$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure7.4Income tax, Q4 FY2024, three months to 2024-12-31$7.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure1.2Income tax, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure0.9Income tax, Q2 FY2025, three months to 2025-06-30$946.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(0.7)Income tax, Q3 FY2025, three months to 2025-09-30−$657.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure0.4Income tax, Q4 FY2025, three months to 2025-12-31$376.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure1.0Income tax, Q1 FY2026, three months to 2026-03-31$985.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure1.7Income tax, Q2 FY2026, three months to 2026-06-30$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Net income$m(131)Net income, Q3 FY2023, three months to 2023-09-30−$130.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure(178)Net income, Q4 FY2023, three months to 2023-12-31−$178.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(148)Net income, Q1 FY2024, three months to 2024-03-31−$147.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure162Net income, Q2 FY2024, three months to 2024-06-30$162.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure(121)Net income, Q3 FY2024, three months to 2024-09-30−$121.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure(81.0)Net income, Q4 FY2024, three months to 2024-12-31−$81.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure519Net income, Q1 FY2025, three months to 2025-03-31$518.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure107Net income, Q2 FY2025, three months to 2025-06-30$106.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(202)Net income, Q3 FY2025, three months to 2025-09-30−$202.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure17.5Net income, Q4 FY2025, three months to 2025-12-31$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(9.5)Net income, Q1 FY2026, three months to 2026-03-31−$9.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure(53.4)Net income, Q2 FY2026, three months to 2026-06-30−$53.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Diluted EPS$ per share(1.26)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figurenot reported(1.05)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure0.99Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure(0.76)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figurenot reported2.93Diluted EPS, Q1 FY2025, three months to 2025-03-31$2.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure0.62Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(1.25)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure(0.32)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Basic EPS$ per share(1.26)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figurenot reported(1.05)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure1.09Basic EPS, Q2 FY2024, three months to 2024-06-30$1.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure(0.76)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figurenot reported3.22Basic EPS, Q1 FY2025, three months to 2025-03-31$3.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure0.66Basic EPS, Q2 FY2025, three months to 2025-06-30$0.66 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(1.25)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figurenot reported(0.06)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure(0.32)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure

Balance sheet

Cash and equivalents$191.5m, Q2 FY2026
Long-term debt$291.5m, Q2 FY2026
Shareholders' equity−$190.7m, Q2 FY2026
Novavax Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m651Cash and equivalents, Q3 FY2023, at 2023-09-30$651.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001000694-23-000055.Report this figure569Cash and equivalents, FY2023, at 2023-12-31$568.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001000694-26-000007.Report this figure481Cash and equivalents, Q1 FY2024, at 2024-03-31$480.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-10, accession 0001000694-24-000031.Report this figure680Cash and equivalents, Q2 FY2024, at 2024-06-30$680.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001000694-24-000035.Report this figure574Cash and equivalents, Q3 FY2024, at 2024-09-30$573.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure530Cash and equivalents, FY2024, at 2024-12-31$530.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001000694-26-000007.Report this figure263Cash and equivalents, Q1 FY2025, at 2025-03-31$263.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure254Cash and equivalents, Q2 FY2025, at 2025-06-30$253.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure268Cash and equivalents, Q3 FY2025, at 2025-09-30$268.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure241Cash and equivalents, FY2025, at 2025-12-31$240.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure228Cash and equivalents, Q1 FY2026, at 2026-03-31$228.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure191Cash and equivalents, Q2 FY2026, at 2026-06-30$191.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Current assets$m1,007Current assets, Q3 FY2023, at 2023-09-30$1.01bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001000694-23-000055.Report this figure1,144Current assets, FY2023, at 2023-12-31$1.14bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001000694-25-000004.Report this figure727Current assets, Q1 FY2024, at 2024-03-31$727.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001000694-24-000031.Report this figure1,203Current assets, Q2 FY2024, at 2024-06-30$1.20bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001000694-24-000035.Report this figure1,104Current assets, Q3 FY2024, at 2024-09-30$1.10bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure1,129Current assets, FY2024, at 2024-12-31$1.13bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001000694-26-000007.Report this figure868Current assets, Q1 FY2025, at 2025-03-31$868.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure920Current assets, Q2 FY2025, at 2025-06-30$919.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure975Current assets, Q3 FY2025, at 2025-09-30$974.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure978Current assets, FY2025, at 2025-12-31$978.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure851Current assets, Q1 FY2026, at 2026-03-31$850.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure771Current assets, Q2 FY2026, at 2026-06-30$771.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Total assets$m1,657Total assets, Q3 FY2023, at 2023-09-30$1.66bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001000694-23-000055.Report this figure1,797Total assets, FY2023, at 2023-12-31$1.80bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001000694-25-000004.Report this figure1,354Total assets, Q1 FY2024, at 2024-03-31$1.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001000694-24-000031.Report this figure1,819Total assets, Q2 FY2024, at 2024-06-30$1.82bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001000694-24-000035.Report this figure1,712Total assets, Q3 FY2024, at 2024-09-30$1.71bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure1,560Total assets, FY2024, at 2024-12-31$1.56bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001000694-26-000007.Report this figure1,293Total assets, Q1 FY2025, at 2025-03-31$1.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure1,337Total assets, Q2 FY2025, at 2025-06-30$1.34bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure1,180Total assets, Q3 FY2025, at 2025-09-30$1.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure1,177Total assets, FY2025, at 2025-12-31$1.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure1,043Total assets, Q1 FY2026, at 2026-03-31$1.04bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure956Total assets, Q2 FY2026, at 2026-06-30$955.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Current liabilities$m1,469Current liabilities, Q3 FY2023, at 2023-09-30$1.47bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001000694-23-000055.Report this figure1,635Current liabilities, FY2023, at 2023-12-31$1.64bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001000694-25-000004.Report this figure804Current liabilities, Q1 FY2024, at 2024-03-31$804.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001000694-24-000031.Report this figure1,158Current liabilities, Q2 FY2024, at 2024-06-30$1.16bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001000694-24-000035.Report this figure1,181Current liabilities, Q3 FY2024, at 2024-09-30$1.18bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure1,154Current liabilities, FY2024, at 2024-12-31$1.15bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001000694-26-000007.Report this figure422Current liabilities, Q1 FY2025, at 2025-03-31$422.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure389Current liabilities, Q2 FY2025, at 2025-06-30$389.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure430Current liabilities, Q3 FY2025, at 2025-09-30$429.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure460Current liabilities, FY2025, at 2025-12-31$459.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure342Current liabilities, Q1 FY2026, at 2026-03-31$342.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure331Current liabilities, Q2 FY2026, at 2026-06-30$330.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Total liabilities$m2,336Total liabilities, Q3 FY2023, at 2023-09-30$2.34bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001000694-23-000055.Report this figure2,514Total liabilities, FY2023, at 2023-12-31$2.51bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001000694-25-000004.Report this figure2,221Total liabilities, Q1 FY2024, at 2024-03-31$2.22bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001000694-24-000031.Report this figure2,250Total liabilities, Q2 FY2024, at 2024-06-30$2.25bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001000694-24-000035.Report this figure2,239Total liabilities, Q3 FY2024, at 2024-09-30$2.24bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure2,184Total liabilities, FY2024, at 2024-12-31$2.18bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001000694-26-000007.Report this figure1,369Total liabilities, Q1 FY2025, at 2025-03-31$1.37bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure1,299Total liabilities, Q2 FY2025, at 2025-06-30$1.30bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure1,337Total liabilities, Q3 FY2025, at 2025-09-30$1.34bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure1,304Total liabilities, FY2025, at 2025-12-31$1.30bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure1,188Total liabilities, Q1 FY2026, at 2026-03-31$1.19bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure1,146Total liabilities, Q2 FY2026, at 2026-06-30$1.15bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported244Long-term debt, FY2025, at 2025-12-31$244.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure291Long-term debt, Q1 FY2026, at 2026-03-31$291.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure291Long-term debt, Q2 FY2026, at 2026-06-30$291.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure
Short-term borrowings$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(678)Shareholders' equity, Q3 FY2023, at 2023-09-30−$678.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure(717)Shareholders' equity, FY2023, at 2023-12-31−$716.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001000694-26-000007.Report this figure(867)Shareholders' equity, Q1 FY2024, at 2024-03-31−$867.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure(432)Shareholders' equity, Q2 FY2024, at 2024-06-30−$431.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure(526)Shareholders' equity, Q3 FY2024, at 2024-09-30−$526.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure(624)Shareholders' equity, FY2024, at 2024-12-31−$623.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(75.6)Shareholders' equity, Q1 FY2025, at 2025-03-31−$75.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure37.6Shareholders' equity, Q2 FY2025, at 2025-06-30$37.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(157)Shareholders' equity, Q3 FY2025, at 2025-09-30−$156.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure(128)Shareholders' equity, FY2025, at 2025-12-31−$127.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(145)Shareholders' equity, Q1 FY2026, at 2026-03-31−$144.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure(191)Shareholders' equity, Q2 FY2026, at 2026-06-30−$190.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure

Cash flow

Operating cash flow−$72.8m, Q2 FY2026
Novavax Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(39.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$39.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001000694-24-000043. Derived: 9-month figure less the 6-month figure.Report this figure(177)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$176.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(83.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$83.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure314Operating cash flow, Q2 FY2024, three months to 2024-06-30$314.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001000694-25-000029. Derived: 6-month figure less the 3-month figure.Report this figure(145)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$144.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001000694-25-000046. Derived: 9-month figure less the 6-month figure.Report this figure(173)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$173.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(186)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$185.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure(127)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$127.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001000694-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure108Operating cash flow, Q3 FY2025, three months to 2025-09-30$107.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001000694-25-000046. Derived: 9-month figure less the 6-month figure.Report this figure(39.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$39.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001000694-26-000007. Derived: 12-month figure less the 9-month figure.Report this figure(32.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$32.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure(72.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$72.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001000694-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)164.57m, Q2 FY2026
Novavax Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares78.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3078,274,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001000694-23-000055.Report this figure86.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3186,158,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001000694-24-000031.Report this figure104Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30104,065,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001000694-24-000035.Report this figure103Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30103,429,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001000694-24-000043.Report this figure140Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31139,916,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001000694-25-000021.Report this figure166Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30165,855,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001000694-25-000029.Report this figure160Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30160,049,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure178Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31177,625,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure177Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30177,215,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure162Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30162,353,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001000694-25-000046.Report this figure163Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31163,276,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-030917.Report this figure165Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30164,574,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure

Shares outstanding: 164.95mShares outstanding, period not labelled, at 2026-07-31164,945,726 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001000694-26-000018.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. Listed shows no prices and gives no investment advice.